The influence of recombinant human tumor necrosis factor α and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro

Leukemia Research

Volumn 21, Issue 9, 1997, Pages 857-865

  Korycka, Anna ^b   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

2 CdA; Cultures in vitro; Interactions; Muteins; Myeloid leukemias; rhTNF

Indexed keywords

CLADRIBINE; COMPLEMENTARY DNA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SYNTHETIC DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIGENS, CD; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; CLADRIBINE; DRUG SYNERGISM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR STEM CELL ASSAY; TUMOR STEM CELLS;

EID: 0030723090     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00058-1     Document Type: Article

References (36)

1. Zhang, Y., Harada, A., Bluethmann, H., Wang, J. B., Nakao, S., Mukaida, N. and Matsushima, K., Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vitro and potent inhibition of progenitor cell proliferation by TNFα in vitro. Blood, 1995, 86, 2930.
2. Bacx, B., Broeders, L., Bot, F. J. and Lowenberg, B., Positive and negative effects of tumor necrosis factor on colony growth from higly purified normal marrow progenitors. Leukemia, 1991, 5, 66.
3. Caux, C., Favre, C., Saeland, S., Duvert, V., Durand, I., Mannoni, P. and Banchereau, J., Potentiation of early hematopoiesis by tumor necrosis factor α is followed by inhibition of granulopoietic differentiation and proliferation. Blood, 1991, 78, 635.
4. Ulrich, T. R., Castillo, J. D. and Yin Songmei, Tumor necrosis factor exerts dose dependent effects on erythropoiesis and myelopoiesis in vivo. Experimental Hematology, 1990, 18, 311.
5. Warzocha, K., Góra-Tybor, J., Kwinkowski, M., Szymańska, B. and Robak, T., A comparison of antileukaemic effect of recombinant human tumor necrosis factor α and its muteins on leukaemia L1210 and P388 in mice. Mediators of Inflammation, 1994, 3, 411.
6. Lahdevirta, I., Maury, C. P. J., Teppo, A. M. and Repo, H., Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. American Journal of Medicine, 1988, 85, 289.
7. Lindeman, A., Ludwig, W. D., Oster, W., Mertelsman, R. and Herrman, F., High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood, 1989, 73, 880.
8. Góra-Tybor, J., Warzocha, K. and Robak, T., The influence of 2-chlorodeoxyadenosine in combination with tumor necrosis factor-α on murine leukaemias L1210 and P388. Mediators of Inflammation, 1995, 4, 205.
9. Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N. and Lejeune, F. J., High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. Journal of Clinical Oncology, 1992, 10, 52.
10. Ktysik, J., Konarzewska-Zglińska, A., Gałao̧zka, G., Uznański, B., Okruszek, A., Guga, P., Wilk, A., Koziołkiewicz, M., Tchórzewski, H., Zembala, M. and Stec, J. W., Synthesis and expression in E. coli of the gene for human tumor necrosis factor. Archivum Immunologiac et Therapiac Experimentalis, 1991, 39, 349.
11. Tchórzewski, H., Zeman, K., Kantorski, J., Paleolog, E., Kahan, M., Feldman, M., Kwinkowski, M., Guga, P., Szymańska, B., Parniewski, P., Wilk, A. and Jarosz, J., The effect of tumor necrosis factor α (TNFα) muteins on human neutrophils in vitro. Mediators of Inflammation, 1993, 2, 41.
12. Tchórzewski, H., Zeman, K., Paleolog, E., Brennan, F., Feldman, B., Guga, P., Kwinkowski, M., Szymańska, B., Jarosz, J., Parniewski, P. and Kocur, E., The effects of tumor necrosis factor (TNF) derivatives on TNF receptors. Cytokine, 1993, 5, 125.
13. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G. and Sultan, C., Proposals for the classification of the acute leukaemias. British Journal of Haematology, 1976, 33, 451.
14. Kazimierczuk, Z., Vilpo, J., Hildebrand, C. and Wright, G., Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6disubstituted purines. Journal of Medical Chemistry, 1990, 33, 1683.
15. Hibbin, J. A., Nioku, O. S., Matutes, E., Lewis, M. and Goldman, M., Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. British Journal of Haematology, 1984, 57, 495.
16. Iscove, N. M, Sieber, F. and Winterhalter, K. H., Erythroid colony formation in cultures of mouse and human bone marrow. Analysis of the requirement chromatography on agarose-concanavalin A. American Journal of Cell Physiology, 1974, 83, 309.
17. Buick, R. N., Till, J. E. and McCulloch, E. A., Colony assay for proliferative blasts cells circulating in myeloblastic leukemia. Lancet, 1977, 1, 862.
18. Korycka, A. and Robak, T., The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukemic blasts (CFU-L) in the culture in vitro. Archivum Immunologiac et Therapiac Experimentalis, 1991, 39, 495.
19. Kristensen, J., Nygren, P., Liliemark, J., Fridborg, H., Kiliander, A., Simonsson, B., Oberg, G. and Larsson, R., Interactions between cladribine (2-CdA) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myeloid leukemia. Leukemia, 1994, 8, 1712.
20. Depraetere, S. and Joniau, M., Potentiation of tumor necrosis factor-mediated cytotoxicity on human myeloid cell lines: effects of interferons versus dimethylsulphoxide. Leukemia Research, 1995, 19, 803.
21. Fahlman, C., Jacobsen, F. W., Veiby, O. P., McNiece, I. K., Blomhoff, H. K. and Jacobsen, S. E., Tumor necrosis factor α (TNFα) potently enhances in vitro macrophage production from primitive murine hemopoietic progenitor cells in combination with stem cell factor and interleukin7: novel stimulatory role of p55 TNF receptors. Blood, 1994, 84, 1528.
22. Khoury, E., Andre, C., Pontvert-Deluq, S., Drenou, B., Baillou, C., Guigon, M., Najman, A. and Lemoine, F. M., Tumor necrosis factor α (TNFα) downregulates c-kit protooncogene product expression in normal and acute myeloid leukemia CD34 +cells via p55 TNF receptors. Blood, 1994, 84, 2506.
23. Reath, U., Schmid, J., Karck, U., Kempeni, J., Schlick, E. and Kaufman, M., Phase II trial of recombinant human tumor necrosis factor in patients with malignant ascites from ovarian carcinomas and non-ovarian tumors with intraperitoneal spread. Proceedings of the American Society of Clinical Oncology, 1991, 10, 187.
24. Robak, T., Korycka, A., Góra-Tybor, J., PiotrowskaWrzesień, A. and Krykowski, E., The influence of recombinant human tumor necrosis factor on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukemic blasts (CFU-L) in cultures in vitro. Archivum Immunologiac et Therapiac Experimentalis, 1991, 40, 339.
25. Ferrajoli, A., Talpaz, M., Kurzrock, R. and Estrov, Z., Analysis of the effects of tumor inhibitors on human hematopoiesis. Stem Cells Dayton, 1993, 11, 112.
26. Carter, A., Haddad, N., Draxler, I., Israeli, E., Raz, B. and Rowe, J. M., Expression and role in growth regulation of tumor necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. British Journal of Haematology, 1996, 92, 116.
27. Rusten, L. R., Jacobsen, F. W., Lesslauer, W., Loetscher, H., Smeland, E. B. and Jacobsen, S. E. W., Bifunctional effect of tumor necrosis factor α (TNFα) on the growth of mature and primitive hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors. Blood, 1994, 83, 3152.
28. Piro, L. D., 2-Chlorodeoxyadenosine treatment of lymphoid malignances. Blood, 1992, 80, 843.
29. Robak, T., Blasińska-Morawiec, M., Krykowski, E., Hansz, J., Komarnicki, M., Kazimierczak, M., Konopka, L., Maj, S., Hellmann, A., Zaucha, J. M., Urasiński, I., Zdziarska, B., Kotlarek-Haus, S., Usnarska-Zubkiewicz, L., Kutarowska, Z., Dwilewicz-Trojaczek, J., Hołowiecki, J., Krawczyk-Kulís, M. and Grieb, P., 2-Chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusions in the treatment of patients with hairy cell leukemia. Leukemia Lymphoma, 1996, 22, 107.
30. Kornblau, S. M., Gandhi, V., Andreeff, H. M., Beran, M., Kantarjian, H. M., Koller, C. A., O'Brien, S., Plunkett, W. and Estey, E., Clinical and laboratory studies of 2chlorodeoxyadenosine±cytosine arabinoside for relapsed or refractory acute myeloid leukemia in adults. Leukemia, 1996, 10, 1563.
31. Saven, A., Piro, L. D., Lemon, R., Figueroa, M. L., Kosty, M., Ellison, D. J. and Beutler, E., Complete hematologie remission in chronic-phase, Philadelphia-chromosomepositive, chronic myelogenous leukemia after 2chlorodeoxyadenosine. Cancer, 1994, 73, 2953.
32. Robak, T., Korycka, A. and Góra-Tybor, J., The interaction of 2-chlorodeoxy-adenosine (2-CdA) and interferon α (IFNα) on normal and myeloid leukemia hematopoiesis in vitro. Leukemia Research, 1994, 18, 275.
33. Robak, T. and Korycka, A., The comparison of 2chlorodeoxyadenosine (2-CdA) in combination with interferon α (IFNα) or interferon γ (IFNγ) on granulocytemacrophage progenitor cells (CFU-GM) and clonogenic leukemic blasts (CFU-L) in culture in vitro. Leukemia Lymphoma, 1996, 21, 161.
34. Robertson, L. E., Chubb, S., Meyn, R. E., Story, M., Ford, R., Hittelman, W. N. and Plunkett, W., Induction of apoptotic cell death in chronic lymphocytic leukemia by 2chloro-2-deoxyadenisine and 9-b-D-arabinosyl-2-fluoroadenine. Blood, 1993, 36, 635.
35. Wu, Y.-L., Jiang, X.-R., Alien, P. D., Jia, L., Dronfield, D. M., Newland, A. C. and Kelsey, S. M., Modulation of surface TNF expression by human leukaemic cells alters their sensitivity to exogenous TNF. Leukemia Research, 1996, 20, 47.
36. Selleri, C., Sato, T., Anderson, S., Young, N. S. and Maciejewski, J. P., Interferon gamma and tumor necrosis factor suppress both early and late stages of hematopoiesis and induce programmed cell death. Journal of Cellular Physiology, 1995, 165, 538.